US Patent Issued to The Board of Regents of the University of Oklahoma on Feb. 3 for "Gene signatures for cancer characterization and treatment" (Oklahoma Inventor)

ALEXANDRIA, Va., Feb. 3 -- United States Patent no. 12,540,361, issued on Feb. 3, was assigned to The Board of Regents of the University of Oklahoma (Norman, Okla.).

"Gene signatures for cancer characterization and treatment" was invented by Maria Jesus Ruiz Echevarria (Edmond, Okla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An assay system and method for generating quantitative data for a subject and a method for treating prostate cancer in a subject by determining an expression level of a biomarker panel in a sample obtained from the subject, the biomarker panel including the genes CDC45, CENPI, CLSPN, ERCC6L, EXO1, NCAPG, BUB1B, CDK1, NUSAP1, RAD51, and RRM2 and optionally E2F7 and/or GSG2, wherein t...